Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Advaxis Inc. (ADXS)

0.41   -0.011 (-2.61%) 10-01 08:25
Open: 0.42 Pre. Close: 0.421
High: 0.45 Low: 0.4023
Volume: 1,397,401 Market Cap: 27M
Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. The company is headquartered in Princeton, New Jersey and currently employs 35 full-time employees. These immunotherapies are based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. These Lm-LLO strains integrate multiple functions into a single immunotherapy as they access and direct antigen presenting cells to stimulate anti-tumor T-cell immunity, stimulate and activate the immune system with the equivalent of multiple adjuvants, and simultaneously reduce tumor protection in the tumor microenvironment to enable the T-cells to eliminate tumors. Axalimogene filolisbac is its lead Lm-LLO immunotherapy product candidate for the treatment of Human Papilloma Virus-associated cancers. ADXS-PSA is its Lm-LLO immunotherapy product candidate that targets the Prostate Specific Antigen (PSA) associated with prostate cancer.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.45 - 0.452 0.452 - 0.453
Low: 0.396 - 0.398 0.398 - 0.399
Close: 0.407 - 0.41 0.41 - 0.412

Technical analysis

as of: 2020-09-30 4:38:19 PM
Stoxline posted a BUY today, downgraded from strong buy. Upward movement continues, but could change at any time.
Target: Six months: 0.55     One year: 0.64
Support: Support1: 0.34    Support2: 0.28
Resistance: Resistance1: 0.47    Resistance2: 0.55
Pivot: 0.42
Moving Average: MA(5): 0.39     MA(20): 0.42
MA(100): 0.57     MA(250): 0.63
MACD: MACD(12,26): -0.03     Signal(9): -0.03
Stochastic oscillator: %K(14,3): 43.80     %D(3): 36.30
RSI: RSI(14): 41.32
52-week: High: 1.48  Low: 0.26  Change(%): 23.9
Average Vol(K): 3-Month: 123287  10-Days: 241305

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ADXS has closed above bottom band by 41.7%. Bollinger Bands are 32.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 01 Oct 2020
Advaxis, Inc. (NASDAQ:ADXS) Adds 6.47% in a week: What’s Lifting the Stock? - Marketing Sentinel

Tue, 29 Sep 2020
ADVAXIS, INC. (NASDAQ:ADXS) Files An 8-K Entry into a Material Definitive Agreement - Market Exclusive

Tue, 29 Sep 2020
Advaxis, Inc. Adopts Limited Duration Stockholder Rights Plan - GlobeNewswire

Mon, 28 Sep 2020
Advaxis Inc. (ADXS) volume hits 2.55 million: A New Opening for Investors - News Daemon

Mon, 28 Sep 2020
An in-depth look at the Advaxis, Inc. (ADXS) stock - Marketing Sentinel

Mon, 28 Sep 2020
Advaxis Inc. (NASDAQ:ADXS) Receive IND Clearance From The FDA For Initiation Of Phase 1 ADXS Clinical Study - BP Journal

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 66
Shares Float (M) 53
% Held by Insiders 0.47
% Held by Institutions 19.36
Shares Short (K) 1,450
Shares Short P. Month (K) 1,420

Stock Financials

EPS -0.564
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.500
Profit Margin
Operating Margin -11031.89
Return on Assets (ttm) -36.4
Return on Equity (ttm) -74.8
Qtrly Rev. Growth
Gross Profit (p.s.) 0.315
Sales Per Share 0.004
EBITDA (p.s.) -0.404
Qtrly Earnings Growth
Operating Cash Flow (M) -28
Levered Free Cash Flow (M) -18

Stock Valuations

PE Ratio -0.73
PEG Ratio
Price to Book value 0.82
Price to Sales 106.91
Price to Cash Flow -0.98

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.